Thioredoxin specifically cross-desensitizes monocytes to MCP-1

Sabrina Pagliei, Pietro Ghezzi, Cinzia Bizzarri, Vilma Sabbatini, Giada Frascaroli, Silvano Sozzani, Gianfranco Caselli, Riccardo Bertini

Research output: Contribution to journalArticlepeer-review


Thioredoxin (Trx) is a protein disulfide oxidoreductase which can be secreted and acts as a cytokine. As we recently reported that Trx is chemotactic, we investigated whether it desensitizes monocytes or PMN to other chemokines. Preincubation for 15 min with Trx inhibited the chemotactic response of monocytes to MCP-1, but not to fMLP. This effect was independent of whether Trx was present during the chemotaxis assay or only during the preincubation. Preincubation (5 min) with Trx also inhibited the increase in intracellular Ca2+ induced by MCP-1 in monocytes, but not that induced by fMLP. Preincubation with Trx did not affect the chemotactic response induced in PMN by IL-8. The inhibition of chemotactic and Ca2+ responses to MCP-1 in monocytes was not due to a down-regulation of the MCP-1 receptor, as shown by receptor binding studies. The Ca2+ response to MCP-1 was also inhibited by Trx in a CCR2-transfected cell line. It is suggested that Trx inhibits monocyte responses to chemokines by acting downstream of the chemokine receptors. Since there are high concentrations of circulating Trx in infection and inflammatory diseases, this might act as an inhibitor of monocyte migration in vivo.

Original languageEnglish
Pages (from-to)261-267
Number of pages7
JournalEuropean Cytokine Network
Issue number2
Publication statusPublished - 2002


  • MCP-1
  • Monocytes
  • Thioredoxin

ASJC Scopus subject areas

  • Cell Biology
  • Immunology


Dive into the research topics of 'Thioredoxin specifically cross-desensitizes monocytes to MCP-1'. Together they form a unique fingerprint.

Cite this